These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 16227948

  • 1. The role of menopausal hormone therapy in preventing osteoporotic fractures: a critical review of the clinical evidence.
    Col NF, Bowlby LA, McGarry K.
    Minerva Med; 2005 Oct; 96(5):331-42. PubMed ID: 16227948
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
    Lekander I, Borgström F, Ström O, Zethraeus N, Kanis JA.
    Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
    [Abstract] [Full Text] [Related]

  • 3. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010 Feb; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [Abstract] [Full Text] [Related]

  • 4. How to manage osteoporosis after the menopause.
    Compston J.
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1007-19. PubMed ID: 16301194
    [Abstract] [Full Text] [Related]

  • 5. Long-term estrogen and hormone replacement therapy for the prevention and treatment of osteoporosis.
    Levine JP.
    Curr Womens Health Rep; 2003 Jun; 3(3):181-6. PubMed ID: 12734027
    [Abstract] [Full Text] [Related]

  • 6. [The effect of hormone replacement therapy on bone mineral content and on fractures].
    Eiken PA.
    Ugeskr Laeger; 1997 Jan 27; 159(5):570-6. PubMed ID: 9045445
    [Abstract] [Full Text] [Related]

  • 7. Prevention of osteoporotic fractures in post-menopausal women.
    Compston J.
    Baillieres Best Pract Res Clin Endocrinol Metab; 2000 Jun 27; 14(2):251-64. PubMed ID: 11035905
    [Abstract] [Full Text] [Related]

  • 8. Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
    Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.
    Bone; 2004 Apr 27; 34(4):728-35. PubMed ID: 15050905
    [Abstract] [Full Text] [Related]

  • 9. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 3. Effects of ovarian hormone therapy on skeletal and extraskeletal tissues in women.
    Josse RG.
    CMAJ; 1996 Oct 01; 155(7):929-34. PubMed ID: 8837542
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of alendronate and risedronate for postmenopausal osteoporosis.
    Iwamoto J, Takeda T, Sato Y.
    Curr Med Res Opin; 2006 May 01; 22(5):919-28. PubMed ID: 16709313
    [Abstract] [Full Text] [Related]

  • 11. Estrogen replacement therapy in the elderly.
    Paganini-Hill A.
    Zentralbl Gynakol; 1996 May 01; 118(5):255-61. PubMed ID: 8701621
    [Abstract] [Full Text] [Related]

  • 12. Prevention and treatment of osteoporosis with hormone replacement therapy.
    Christiansen C.
    Int J Fertil Menopausal Stud; 1993 May 01; 38 Suppl 1():45-54. PubMed ID: 8499959
    [Abstract] [Full Text] [Related]

  • 13. Osteoporotic compression fractures of the spine; current options and considerations for treatment.
    Kim DH, Vaccaro AR.
    Spine J; 2006 May 01; 6(5):479-87. PubMed ID: 16934715
    [Abstract] [Full Text] [Related]

  • 14. [Absolute risk for fracture and WHO guideline. Selection of drugs for the prevention of fractures in postmenopausal women].
    Gorai I, World Health Organization.
    Clin Calcium; 2007 Jul 01; 17(7):1090-6. PubMed ID: 17607077
    [Abstract] [Full Text] [Related]

  • 15. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Lamy O, Krieg MA.
    Rev Med Suisse Romande; 2002 Aug 01; 122(8):377-81. PubMed ID: 12357730
    [Abstract] [Full Text] [Related]

  • 16. Bone health and osteoporosis in postmenopausal women.
    de Villiers TJ.
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb 01; 23(1):73-85. PubMed ID: 19027366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
    Prescrire Int; 2005 Dec 01; 14(80):207-11. PubMed ID: 16397977
    [Abstract] [Full Text] [Related]

  • 19. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
    Siminoski K, Josse RG.
    CMAJ; 1996 Oct 01; 155(7):962-5. PubMed ID: 8837547
    [Abstract] [Full Text] [Related]

  • 20. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H.
    Clin Calcium; 2008 Oct 01; 18(10):1442-50. PubMed ID: 18830041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.